Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian I Carr

Showing results (101-110 of 187) with videos related to

Pageof 19
Sort By:
Oncology|September 26, 2012
Small hepatocellular carcinomas and thrombocytopeniaBrian I Carr, Vito Guerra, Massimo De Giorgio, et al.
Expert Review of Gastroenterology & Hepatology|April 28, 2015
MEK 1/2 inhibitors in the treatment of hepatocellular carcinomaAntonio Facciorusso, Raffaele Licinio, Brian I Carr, et al.
World Journal of Medical Oncology|July 14, 2025
Transplant Versus Non-Transplant Hepatocellular Carcinoma Patient Characteristics And SurvivalBrian I Carr, Volkan Ince, Harika Gozukara Bag, et al.
Cancer|October 13, 2005
Sexual functioning in patients with hepatocellular carcinomaJennifer Steel, Stephanie A Hess, Laura Tunke, et al.
Acta Chirurgica Belgica|May 13, 2022
Critical overview of resection for Bismuth-Corlette type IV perihilar cholangiocarcinomaVeysel Ersan, Sertac Usta, Cemalettin Aydin, et al.
Carcinogenesis|August 21, 2004
Inhibition of rat liver regeneration after partial hepatectomy and induction of ERK phosphorylation by Cpd 5, a K vitamin-based anticancer compoundSiddhartha Kar, Meifang Wang, Kathryn S Rosi, et al.
Oncology|May 10, 2017
Role of Albumin in Growth Inhibition in Hepatocellular CarcinomaEzgi Bağırsakçı, Eren Şahin, Neşe Atabey, et al.
Journal of Gastroenterology and Hepatology|August 14, 2008
Tumor and liver determinants of prognosis in unresectable hepatocellular carcinoma: a case cohort studyBrian I Carr, Shama C Buch, Venkateswarlu Kondragunta, et al.
Hepatology Forum|March 15, 2024
Transplant and non-transplant HCC patients at a single institutionBrian I Carr, Harika Bag, Volkan Ince, et al.
Journal of Cellular Physiology|October 21, 2003
JS-K, a novel non-ionic diazeniumdiolate derivative, inhibits Hep 3B hepatoma cell growth and induces c-Jun phosphorylation via multiple MAP kinase pathwaysZhenggang Ren, Siddhartha Kar, Ziqiu Wang, et al.
Pageof 19

Showing results (101-110 of 187) with videos related to

Sort By:
Pageof 19
Oncology|September 26, 2012
Small hepatocellular carcinomas and thrombocytopeniaBrian I Carr, Vito Guerra, Massimo De Giorgio, et al.
Expert Review of Gastroenterology & Hepatology|April 28, 2015
MEK 1/2 inhibitors in the treatment of hepatocellular carcinomaAntonio Facciorusso, Raffaele Licinio, Brian I Carr, et al.
World Journal of Medical Oncology|July 14, 2025
Transplant Versus Non-Transplant Hepatocellular Carcinoma Patient Characteristics And SurvivalBrian I Carr, Volkan Ince, Harika Gozukara Bag, et al.
Cancer|October 13, 2005
Sexual functioning in patients with hepatocellular carcinomaJennifer Steel, Stephanie A Hess, Laura Tunke, et al.
Acta Chirurgica Belgica|May 13, 2022
Critical overview of resection for Bismuth-Corlette type IV perihilar cholangiocarcinomaVeysel Ersan, Sertac Usta, Cemalettin Aydin, et al.
Carcinogenesis|August 21, 2004
Inhibition of rat liver regeneration after partial hepatectomy and induction of ERK phosphorylation by Cpd 5, a K vitamin-based anticancer compoundSiddhartha Kar, Meifang Wang, Kathryn S Rosi, et al.
Oncology|May 10, 2017
Role of Albumin in Growth Inhibition in Hepatocellular CarcinomaEzgi Bağırsakçı, Eren Şahin, Neşe Atabey, et al.
Journal of Gastroenterology and Hepatology|August 14, 2008
Tumor and liver determinants of prognosis in unresectable hepatocellular carcinoma: a case cohort studyBrian I Carr, Shama C Buch, Venkateswarlu Kondragunta, et al.
Hepatology Forum|March 15, 2024
Transplant and non-transplant HCC patients at a single institutionBrian I Carr, Harika Bag, Volkan Ince, et al.
Journal of Cellular Physiology|October 21, 2003
JS-K, a novel non-ionic diazeniumdiolate derivative, inhibits Hep 3B hepatoma cell growth and induces c-Jun phosphorylation via multiple MAP kinase pathwaysZhenggang Ren, Siddhartha Kar, Ziqiu Wang, et al.
Pageof 19